Archives

by in
Entry Author Date Location
23andMe Adds On: More About The Gene-Test Maker’s Drug R&D Ambitions 03/12/15 San Francisco
23andMe Pharma? That’s the Plan, Says the Genetic Test Maker 03/12/15 San Francisco
As Promised, LTI Pulls In Big Series A to Advance Parkinson’s Drug 02/03/15 Boston
Now Playing: California’s $1 Billion Stem-Cell Renovation Show 02/03/15 National
Attacking Parkinson’s Via Gaucher Link, LTI Ready for Its Series A 01/15/15 Boston
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
West Coast Biotech Roundup: Nevro, Coherus, Xenon, Rock Health, Etc. 11/06/14 San Francisco
Alkermes Spinoff Civitas, Poised for IPO, Sells to Acorda for $525M 09/24/14 Boston
LTI Corrals $5M to Exploit Link Between Gaucher, Parkinson’s 05/12/14 Boston
Backed By a Billionaire, Berg Pharma Aims to Speed Drugmaking 04/02/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Third Rock’s Voyager Hunts For CNS Disorders With Gene Therapy 02/12/14 Boston
Promentis’s $2.9M Series B Round to Fund Human Trials 01/16/14 Wisconsin
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
As Tremor Sufferers Await Remedies, Lift Labs “Cures” Their Tools 10/31/13 San Francisco
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
Civitas Scores $38M Series B For Parkinson’s Drug Push 09/11/13 Boston
Amicus, Biogen Team Up on Parkinson’s Drug Deal 09/10/13 Boston
MI Biotech Roundup: Rockwell, Metabolic Solutions Publish New Data 07/18/13 Detroit
Alkermes Spinout, Civitas, Nabs Second Grant From Fox Foundation 06/18/13 Boston
Prothena of South San Francisco Gets Head Start as Elan Spinoff 01/09/13 San Francisco
In Comeback Study, Acadia Says Drug Controls Parkinson’s Psychosis 11/27/12 San Diego
Startups Progress with Novel Drugs for Parkinson’s Disease 10/29/12 New York
Xconomist of the Week: Evan Snyder—Stem Cell Reality Check 05/25/12 San Diego
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More 01/13/12 Boston
Civitas Charts Positive Data on Inhaled Parkinson’s Drug 01/06/12 Boston
Infinity, Idera, Civitas, & More Boston-Area Life Sciences Headlines 12/02/11 Boston
Rib-X, Skyhook, Michael J. Fox Foundation & More Boston-Area Deals News 11/30/11 Boston
Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug 11/29/11 Boston
23andMe Identifies Possible Protective Gene Against Parkinson’s Disease 10/25/11 San Diego
Page 1 of 2 next page »